Posted On: 02/22/2014 7:47:19 PM
Post# of 63821
$DSCI recovery candles $12.27
called 1/14/14 PoemStone updated here.
Shares Outstanding 17,285,084 a/o Nov 11, 2013
Float Not Available
Derma Sciences: A Not Well Followed Growth Company With Solutions For Diabetic Foot Ulcers
2/19/2014 1:17:00 PM - Seeking Alpha
Cadence: What To Do With The Proceeds And A Post Mortem On A Successful Investment
2/13/2014 3:26:00 PM - Seeking Alpha
3 Micro-Cap Stocks With Triple-Digit Upside
2/5/2014 2:30:00 PM - Investopedia
Can Derma Sciences (DSCI) Continue to Rise? - Tale of the Tape
1/31/2014 7:33:01 AM - Zacks.com
Derma Sciences (DSCI) Jumps: Stock Rises 6.2% - Tale of the Tape
1/30/2014 9:21:01 AM - Zacks.com
Derma Sciences Enters the Skin Substitute Market
with Licensing Agreement for Innovative Amniotic Membrane Wound Care Products
1/14/2014 9:18:00 AM - Business Wire
Emerging Growth Equities, Ltd. Initiates Coverage
of Derma Sciences, Inc. (DSCI) With A BUY Rating And $21.00 Price Target
1/2/2014 9:55:00 AM - PR Newswire
Analysts
called 1/14/14 PoemStone updated here.
Shares Outstanding 17,285,084 a/o Nov 11, 2013
Float Not Available
Derma Sciences: A Not Well Followed Growth Company With Solutions For Diabetic Foot Ulcers
2/19/2014 1:17:00 PM - Seeking Alpha
Cadence: What To Do With The Proceeds And A Post Mortem On A Successful Investment
2/13/2014 3:26:00 PM - Seeking Alpha
3 Micro-Cap Stocks With Triple-Digit Upside
2/5/2014 2:30:00 PM - Investopedia
Can Derma Sciences (DSCI) Continue to Rise? - Tale of the Tape
1/31/2014 7:33:01 AM - Zacks.com
Derma Sciences (DSCI) Jumps: Stock Rises 6.2% - Tale of the Tape
1/30/2014 9:21:01 AM - Zacks.com
Derma Sciences Enters the Skin Substitute Market
with Licensing Agreement for Innovative Amniotic Membrane Wound Care Products
1/14/2014 9:18:00 AM - Business Wire
Emerging Growth Equities, Ltd. Initiates Coverage
of Derma Sciences, Inc. (DSCI) With A BUY Rating And $21.00 Price Target
1/2/2014 9:55:00 AM - PR Newswire
Analysts
(0)
(0)
